Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Condensed Consolidated Statements of Operations
Grant and award revenue	$ 2,169		$ 2,660	$ 966
Operating expenses
Research and development	6,394	$ 8,475	11,823	16,491
General and administrative	2,619	3,439	5,872	6,617
Total operating expenses	9,013	11,914	17,695	23,108
Operating loss	(6,844)	(11,914)	(15,035)	(22,142)
Other income (expense)
Interest income	108	221	167	273
Interest expense	(3,808)	(2,718)	(7,410)	(4,538)
Change in fair value of the Convertible Loan	(5,751)	23,397	(548)	10,372
Total other income (expense), net	(9,451)	20,900	(7,791)	6,107
Net income (loss)	$ (16,295)	$ 8,986	$ (22,826)	$ (16,035)
Per share information:
Net income (loss) per share, basic	$ (0.45)	$ 0.25	$ (0.63)	$ (0.44)
Weighted average shares outstanding, basic	36,193,479	36,154,521	36,189,165	36,139,873
Net loss per share, diluted	$ (0.45)	$ (0.25)	$ (0.63)	$ (0.45)
Weighted average shares outstanding, diluted	36,193,479	58,246,626	36,189,165	58,231,978